# üéØ PHASE 2: ENABLE FORGE - THERAPEUTIC GENERATION

**Duration**: 2-4 weeks  
**Status**: ‚è≥ **NOT STARTED** (waiting for Phase 1)  
**Goal**: Generate therapeutic candidates with safety validation

---

## üéØ **OBJECTIVE**

Enable safe, context-aware therapeutic generation using Evo2 for:
- CRISPR guide RNAs
- Therapeutic protein sequences
- Peptide therapeutics
- mRNA sequences

**Feature Flag**: `EVO2_GENERATION_ENABLED=False` (default OFF)

---

## üìã **TASKS**

### **Task 2.1: Context-Aware Prompting** (3 days)

**Goal**: Rich biological context for better Evo2 generation

**Implementation**:
```python
# api/services/therapeutic_prompt_builder.py

class TherapeuticPromptBuilder:
    def build_prompt(
        self,
        target_gene: str,
        disease: str,
        mechanism: str,  # "inhibit" or "activate"
        gene_context: str,
        binding_sites: dict
    ) -> str:
        return f"""
        # Therapeutic Design Context
        Target: {target_gene}
        Disease: {disease}
        Mechanism: {mechanism}
        
        # Gene Sequence (first 1000bp)
        {gene_context[:1000]}
        
        # Binding Sites
        {binding_sites}
        
        # Constraints
        - GC content: 40-60%
        - No homopolymers >4bp
        - Avoid viral sequences
        
        # Generate therapeutic:
        """
```

**Acceptance**: 10 test generations are biologically plausible

---

### **Task 2.2: Iterative Optimization** (4 days)

**Goal**: Generate ‚Üí Score ‚Üí Refine loop

**Implementation**: See `03_PHASE1_EXPAND_HUNT.mdc` for `TherapeuticOptimizer` class

**Acceptance**: 5/5 test cases achieve score ‚â•0.85 within 10 iterations

---

### **Task 2.3: Safety Validation** (3 days)

**Goal**: Block dangerous sequences

**Checks**:
- Viral content (HIV, SARS, Ebola, Influenza)
- GC content extremes (<30% or >70%)
- Homopolymer runs (>6bp)
- Known toxic sequences

**Acceptance**: 100% of viral sequences blocked

---

## ‚è≥ **DEPENDENCIES**

- **Blocker**: Phase 1 complete
- **Required**: Evo2 service stable
- **Optional**: ChEMBL binding site data

---

**GATE 2 CRITERIA**: See `11_ACCEPTANCE_CRITERIA.mdc`

---

**NEXT**: Phase 3 (Gauntlet - Structural Validation)
